what stimulates glp 1 production GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes glp-1_analogs [TUSOM | Pharmwiki]

GLP-1 Drug Semaglutide Substantially Reduced Heavy Alcohol Consumption and Weight in Patients with Alcohol Use Disorder and Obesity Researchers have reported positive results in the first clinical trial testing the diabetes and weight-loss medicine semaglutide (Ozempic, Wegovy) in treatment-seeking patents with alcohol use disorder (AUD) who were also obese

Appetite and energy effects Some users report that early dosing produces a temporary boost in appetite suppression

There is no published RCT and no long-term human safety data

Both tirzepatide and retatrutide use gradual dose escalation strategies to minimize gastrointestinal side effects, but their specific protocols differ in ways that affect the practical experience of using each compound